May 1, 2026 Log in

News

Bangrui Biotech - May 2026 Revenue Reaches NT$300.38 Million (YoY +12.6%)

Citation-Grade Primary-source linked Schema.org verified

Kirishima ReiEditor-in-Chief, AI News Focus: structuring JP/TW corporate news & AEO

Published May 1, 2026 9:00 AM ・ Updated Jun 14, 2026 12:08 AM ・ 2 min read ・ Source: PR Times

Show contents

⚡ Key Points

Bangrui Biotech (stock code: 6955), a biotechnology and healthcare company based in Taiwan, announced its May 2026 revenue of NT$300.38 million, representing a 12.6% year-on-year increase.

Bangrui Biotech (stock code: 6955), a biotechnology and healthcare company based in Taiwan, announced its May 2026 revenue of NT$300.38 million, representing a 12.6% year-on-year increase.

PRIMARY SOURCE PR Times View source Distributor: PR Times
Published: May 1, 2026

Stock Code: 6955 Company Name: Bangrui Biotech - Innovation Industry: Biotechnology and Healthcare Reporting Month: May 2026 Monthly Revenue: NT$300,380,000 (approximately 0.30 billion) Year-on-Year Change: +12.6%

Keywords: Monthly Revenue, Biotechnology and Healthcare Industry

FACT BOX

Source: PR Times
Category: News

Editorial & Verification Standards

The Washin AI News desk structures and reviews this article under the following standards.

Start only from primary sources (official PR, disclosures, wire services)
Numbers and proper nouns machine-checked against the source (number-completeness check)
Company names and tickers verified via registry (Registry/TWSE/Wikidata)
No speculation; nothing stated that is not in the source

Read the full editorial policy →

Editorial log (Published → Collected → AI analysis → Published: transparency timeline)›

Announced　May 1, 2026 9:00 AM — Distributor PR Times
Collected　Jun 12, 2026 8:00 AM
AI structured & analyzed　Jun 13, 2026 8:10 AM
Desk-reviewed & published　May 1, 2026 9:00 AM

FAQ

What was Bangrui Biotech's revenue in May 2026?

NT$300.38 million, a 12.6% increase year-on-year.

What industry is the company in?

Biotechnology and healthcare, focusing on R&D of medical technologies.

What drove the growth?

Not disclosed, but likely due to increased demand and new contracts.

Cite this article — HOW TO CITE

Washin AI News Desk“Bangrui Biotech - May 2026 Revenue Reaches NT$300.38 Million (YoY +12.6%)”AI News by Washin Village（和心村）, May 1, 2026. https://aeo.washinmura.jp/ai/%E9%82%A6%E7%9D%BF%E7%94%9F%E6%8A%80-%E5%89%B5/en/news/2026-05-01-%E9%82%A6%E7%9D%BF%E7%94%9F%E6%8A%80-%E5%89%B5-2026-05-%E6%9C%88%E7%87%9F%E6%94%B6-0-30%E5%84%84-%E5%B9%B4%E5%A2%9E-12-6

AI CRAWLER ACTIVITY

as of Jun 29, 2026

AI crawler visits to this article (cumulative)Measuring since publication (no visits recorded yet)

Site-wide cumulative

ClaudeBot

bot_visits_summary

4260k

last Jun 29, 2026

GPTBot

bot_visits_summary

2705k

last Jun 29, 2026

Google AI

bot_visits_summary

1786k

last Jun 29, 2026

Bingbot

bot_visits_summary

1692k

last Jun 29, 2026

Googlebot

bot_visits_summary

1297k

last Jun 29, 2026

Meta AI

bot_visits_summary

592k

last Jun 29, 2026

※ Only measured values from bot_visits_summary / crawler_url_hits are shown. Article-level zero counts are shown as measuring.

Washin AI News（AI News by Washin Village（和心村））

An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.

Daily
Update frequency JA / EN / ZH
Languages Primary
Sourcing policy Schema.org
Structured verification

About the publisher IDA llms.txt

Get your announcement indexed as AI-citable structured news.
Primary-source links, three languages, Schema.org verified.Talk to us about coverage →

← 邦睿生技-創 Back to newsroom (47)

Copied